12:00 AM
 | 
Nov 17, 2011
 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine/metabolic disease

This week in therapeutics
Indication Target/marker/pathway Summary Licensing status Publication and contact information
Endocrine/metabolic disease
Obesity Prohibitin...

Read the full 170 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Innovations

Article Purchase

$35 USD
More Info >